Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
RespireRx Pharmaceuticals Inc. (CORX)
|
|
| Operating Efficiency |
|
|
|
|
Annual |
|
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| | Source | Source | Source | Source | Source | Source | Source | Source |
| Turnover Ratios |
| Asset turnover | 0.0 | 0.0 | 0.0 | 13.7 | 25.3 | 62.5 | 0.3 | 0.3 |
| |
| Returns on Capital |
| ROIC (including intangibles) | 31.7% | 48.9% | 28.3% | 45.6% | 122.4% | 182.4% | 255.6% | 244.8% |
| ROE | 25.6% | 41.1% | 23.3% | 38.0% | 97.5% | 154.2% | 183.1% | 197.9% |
| ROA | -1226.0% | -3896.2% | -3831.0% | -1752.6% | -2180.7% | -3622.8% | -3592.7% | -1087.5% |
| |
| Cash Conversion Cycle |
| Days sales outstanding | | | | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Days payables outstanding | | | | | | | | |
| Cash conversion cycle | | | | | | | 0.0 | 0.0 |
|